4
Changes in Ownership
ProMIS Neurosciences Inc. Filed Acc 0001062993-22-019774
Options or other derivatives
- Chief Executive Officer acquired 208,334 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Farfel Gail M Chief Executive Officer | 2022-09-19 | Grant or award · Option (right to buy) | +208,334 | 208,334 | D: show line 1 in the form |
Loading xslF345X03/form4.xml…